tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

URGN Stock Latest News

UroGen Faces Legal Battle Over Misleading FDA Claims
Class ActionUroGen Faces Legal Battle Over Misleading FDA Claims
3d ago
URGN
UroGen Pharma price target lowered to $10 from $36 at Oppenheimer
PremiumThe Fly
UroGen Pharma price target lowered to $10 from $36 at Oppenheimer
4d ago
URGN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
11d ago
TIL
IMNN
UroGen Pharma price target lowered to $15 from $40 at Guggenheim
PremiumThe Fly
UroGen Pharma price target lowered to $15 from $40 at Guggenheim
15d ago
URGN
UroGen Pharma downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
UroGen Pharma downgraded to Neutral from Buy at H.C. Wainwright
16d ago
URGN
UroGen Pharma down over 50% after resuming trading
PremiumThe FlyUroGen Pharma down over 50% after resuming trading
17d ago
URGN
UroGen says FDA panel votes against benefit/risk of UGN-102
Premium
The Fly
UroGen says FDA panel votes against benefit/risk of UGN-102
17d ago
URGN
UroGen Pharma announces outcome of ODAC meeting for UGN-102
Premium
The Fly
UroGen Pharma announces outcome of ODAC meeting for UGN-102
17d ago
URGN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
19d ago
ACAD
AFMD
UroGen Pharma down after FDA posts UGN-102 briefing documents
PremiumThe Fly
UroGen Pharma down after FDA posts UGN-102 briefing documents
22d ago
URGN
TD remains confident in approval after UroGen briefing docs
PremiumThe Fly
TD remains confident in approval after UroGen briefing docs
22d ago
URGN
UroGen sinks 26% to $7.26 after FDA posts briefing docs for UGN-102
PremiumThe Fly
UroGen sinks 26% to $7.26 after FDA posts briefing docs for UGN-102
22d ago
URGN
Positive Buy Rating for UroGen Pharma Driven by Promising UGN-102 Prospects and Strong Financial Position
PremiumRatingsPositive Buy Rating for UroGen Pharma Driven by Promising UGN-102 Prospects and Strong Financial Position
25d ago
URGN
UroGen Pharma Reports Q1 2025 Earnings and Pipeline Progress
Premium
Company Announcements
UroGen Pharma Reports Q1 2025 Earnings and Pipeline Progress
26d ago
URGN
UroGen Pharma’s Earnings Call: Progress and Challenges
Premium
Company Announcements
UroGen Pharma’s Earnings Call: Progress and Challenges
26d ago
URGN
Urogen Pharma’s Promising Developments and High Approval Likelihood: A Buy Recommendation
PremiumRatings
Urogen Pharma’s Promising Developments and High Approval Likelihood: A Buy Recommendation
26d ago
URGN
UroGen Pharma reports Q1 EPS (92c), consensus (80c)
PremiumThe Fly
UroGen Pharma reports Q1 EPS (92c), consensus (80c)
26d ago
URGN
URGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
URGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
29d ago
URGN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
NVS
ABEO
Urogen Pharma’s UGN-102: Promising Efficacy and Market Potential Justify Buy Rating
PremiumRatingsUrogen Pharma’s UGN-102: Promising Efficacy and Market Potential Justify Buy Rating
1M ago
URGN
UroGen Pharma announces patient-reported outcomes on UGN-102
Premium
The Fly
UroGen Pharma announces patient-reported outcomes on UGN-102
1M ago
URGN
UroGen Pharma announces long-term follow up data from OPTIMA II Phase 2b study
Premium
The Fly
UroGen Pharma announces long-term follow up data from OPTIMA II Phase 2b study
1M ago
URGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >